NOVARTIS INDIA LIMITED (NOVARTIND)

NSE: ₹1,353.00
BSE: ₹1,351.20
Stock Performance
Corporate Announcements
Announcement under Regulation 30 (LODR)-Newspaper Publication

Intimation of Newspaper Advertisement of Novartis India Limited ("The Company/ The Target Company") regarding the reasoned recommendations of the Committee of Independent Directors ("IDC").

2026-06-06 19:28:01
Announcement under Regulation 30 (LODR)-Open Offer - Updates

Intimation of Recommendations by the Committee of Independent Directors ("IDC") pursuant to Regulation 26(7) of the SEBI (SAST) Regulations, 2011.

2026-06-04 23:10:23
Announcement under Regulation 30 (LODR)-Open Offer - Updates

Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 relating to the Receipt of the Letter of Offer from Axis Capital Limited (Manager to the Open Offer).

2026-06-04 19:44:45
Announcement under Regulation 30 (LODR)-Newspaper Publication

Intimation of sending Reminder to respective shareholders for transfer of Shares of Novartis India Limited ("The Company") to Investor Education & Protection Fund ("IEPF").

2026-05-30 15:04:18
Compliances-Reg.24(A)-Annual Secretarial Compliance

Annual Secretarial Compliance Report for the financial year ended March 31, 2026.

2026-05-22 16:08:16
Shareholder Meeting / Postal Ballot-Scrutinizer"s Report

Declaration of Voting Results of the Postal Ballot of Novartis India Limited ("The Company") and Scrutinizer's Report.

2026-05-19 14:43:50

Quarterly Financials

Consolidated Standalone
No financial data available for Consolidated.

Yearly Financial Results

Consolidated Standalone
No yearly financial data available for Consolidated.